Effects of Spironolactone and Losartan on Diabetic Nephropathy in a Type 2 Diabetic Rat Model

BACKGROUND: While there is an evidence that the anti-inflammatory properties of spironolactone can attenuate proteinuria in type 2 diabetes, its effects on vascular endothelial growth factor (VEGF) expression in diabetic nephropathy have not been clearly defined. In this study, we examined the effec...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Lee, Mi Young, Shim, Myoung Sook, Kim, Bo Hwan, Hong, Soon Won, Choi, Ran, Lee, Eun Young, Nam, Soo Min, Kim, Gun Woo, Shin, Jang Yel, Shin, Young Goo, Chung, Choon Hee
Formato: Artigo
Idioma:Inglês
Publicado: Korean Diabetes Association 2011
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3122897/
https://ncbi.nlm.nih.gov/pubmed/21738895
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4093/dmj.2011.35.2.130
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares